COST OF THERAPY OF TUMOR NECROSIS FACTOR BLOCKING AGENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN ITALY

被引：0
|
作者：
Fiocco, U. [1 ]
Cantini, F. [2 ]
Cerinic, Matucci M. [3 ]
Ferri, C. [4 ]
Botsios, C. [1 ]
Intorcia, M. [5 ]
Bombardieri, S. [6 ]
机构：
[1] Univ Padua, Padua, Italy
[2] Osped Misericordia & Dolce, Prato, Italy
[3] Univ Florence, Florence, Italy
[4] Univ Modena, I-41100 Modena, Italy
[5] Bristol Myers Squibb Co, Rome, Italy
[6] Univ Pisa, Pisa, Italy
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)66805-2
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A547 / A547
页数：1
相关论文
共 50 条
  • [1] Fcγ receptor type IIIA genotype and response to tumor necrosis factor α-blocking agents in patients with rheumatoid arthritis
    Kastbom, Alf
    Bratt, Johan
    Ernestam, Sofia
    Lampa, Jon
    Padyukov, Leonid
    Soderkvist, Peter
    Skogh, Thomas
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (02): : 448 - 452
  • [2] Discontinuation of DMARDs in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Blocking Agents: An Analysis in the Dutch Rheumatoid Arthritis Monitoring (DREAM) Registry
    van Dartel, Sanne
    Fransen, Jaap
    Kievit, Wietske
    den Broeder, Alfons
    Visser, Henk
    Hartkamp, Andre
    van de Laar, Mart A. F.
    Van Riel, Piet
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S1019 - S1020
  • [3] Cost-effectiveness estimates reported for tumor necrosis factor blocking agents in rheumatoid arthritis refractory to methotrexate - A brief summary
    Maetzel, A
    [J]. JOURNAL OF RHEUMATOLOGY, 2005, 32 : 51 - 53
  • [4] Tumor necrosis factor inhibitor therapy for rheumatoid arthritis
    Naguwa, SM
    [J]. AUTOIMMUNE DISEASES AND TREATMENT: ORGAN-SPECIFIC AND SYSTEMIC DISORDERS, 2005, 1051 : 709 - 715
  • [5] Potentiated Antibodies to Tumor Necrosis Factor-α in the Therapy of Patients with Rheumatoid Arthritis
    L. V. Kozlovskaya
    N. A. Mukhin
    V. V. Rameev
    I. A. Sarkisova
    O. I. Epstein
    [J]. Bulletin of Experimental Biology and Medicine, 2003, 135 (Suppl 7) : 152 - 154
  • [6] Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's disease in patients with rheumatoid arthritis and psoriasis
    Zhou, Mengshi
    Xu, Rong
    Kaelber, David C.
    Gurney, Mark E.
    [J]. PLOS ONE, 2020, 15 (03):
  • [7] Survival during treatment with tumour necrosis factor blocking agents in rheumatoid arthritis
    Flendrie, M
    Creemers, MCW
    Welsing, PMJ
    den Broeder, AA
    van Riel, PLCM
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 30 - 33
  • [8] Weight changes in rheumatoid arthritis patients on anti-tumor necrosis factor agents
    Syed, Reema H.
    Gilliam, Brooke E.
    Pepmueller, Peri H.
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (12): : 4284 - 4284
  • [9] The Influence Of Body Mass Index On The Efficacy Of Tumor Necrosis Factor Blocking Therapy For Rheumatoid Arthritis.
    Visman, Ingrid M.
    van den Oever, Inge A. M.
    Krieckaert, Charlotte L. M.
    Wolbink, Gertjan
    Nurmohamed, Michael T.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S602 - S602
  • [10] Tumor necrosis factor (TNF) inhibitor therapy for rheumatoid arthritis
    Segal, Barbara
    Rhodus, Nelson L.
    Patel, Ketan
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2008, 106 (06): : 778 - 787
12345